In HCV, DILI, cholestasis, IBD, IR injury and other diseases, BACH1 transcriptionally inhibits HO-1 to mediate oxidative stress response, which causes aggravated organ function damage and a rise in related indicators. Here, BACH1 is linked to cholestasis.